JP Morgan Chase
BIOR

JP Morgan Chase’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

JP Morgan Chase’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$11 – 7904
2024
Q3 		$11 Buy
+2
New +$13 ﹤0.01% 7291
2024
Q1 		– Sell
-2
Closed -$26 – 8116
2023
Q4 		$26 Buy
2
+1
+100% +$16 ﹤0.01% 7306
2023
Q3 		$22 Buy
+1
New +$32 ﹤0.01% 7155
2023
Q2 		– Sell
-224
Closed -$6K – 7575
2023
Q1 		$6K Buy
+224
New +$7.59K ﹤0.01% 6228
2022
Q1 		– Sell
-22
Closed -$8.35K – 7223
2021
Q4 		$12K Buy
+22
New +$15.8K ﹤0.01% 6314
2021
Q3 		– Sell
-66
Closed -$59K – 6970
2021
Q2 		$59K Sell
66
-127
-66% -$97.1K ﹤0.01% 5689
2021
Q1 		$230K Buy
193
+155
+408% +$214K ﹤0.01% 5093
2020
Q4 		$51K Buy
38
+27
+245% +$39.6K ﹤0.01% 5150
2020
Q3 		$23K Buy
+11
New +$24.9K ﹤0.01% 5121

JP Morgan Chase's BIOR Position: Q4 2024 in Review

JP Morgan Chase sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2024, closing a stake of 2 shares — an estimated $11 sold.

JP Morgan Chase first reported a position in BIOR in Q3 2020 and held it in 9 quarters. The position peaked at $230K in Q1 2021. 0 funds tracked by Wall St. Rank hold BIOR as of Q4 2024.

  • JP Morgan Chase reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • JP Morgan Chase sold 2 Biora Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $11.
  • JP Morgan Chase first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • JP Morgan Chase's Biora Therapeutics, Inc. Common Stock position peaked at $230K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2024.

Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.